Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice-Reference-Cited by-同舟云学术

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

Published:2015-09-11 Issue:31 Volume:6 Page:31877-31888
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Weber Helga¹,Leal Pamela¹,Stein Stefan²,Kunkel Hana²,García Patricia³,Bizama Carolina³,Espinoza Jaime A.³,Riquelme Ismael¹,Nervi Bruno⁴,Araya Juan C.¹,Grez Manuel²,Roa Juan C.³

Affiliation:

1. Department of Pathology, Center of Genetic and Immunological Studies (CEGIN) and Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile

2. Gene Therapy Unit, Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany

3. Department of Pathology, UC-Center for Investigational Oncology (CITO), Advanced Center for Chronic Diseases (ACCDiS), School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

4. Department of Hematology Oncology, UC-Center for Investigation in Translational Oncology (CITO), School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

2. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy;Journal of Medicinal Chemistry;2023-09-19

3. Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma;International Journal of Molecular Sciences;2023-03-27

4. D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy;Cancers;2021-07-20

5. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer;Cancers;2020-03-25